Parsons Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.47M Buy
23,390
+780
+3% +$267K 0.38% 56
2026
Q1
$7.96M Buy
22,610
+1,216
+6% +$433K 0.36% 58
2025
Q4
$7M Buy
21,394
+159
+0.7% +$50.4K 0.38% 53
2025
Q3
$5.99M Sell
21,235
-330
-2% -$95.7K 0.34% 58
2025
Q2
$6.02M Buy
21,565
+215
+1% +$60.9K 0.37% 58
2025
Q1
$6.65M Sell
21,350
-188
-0.9% -$55.5K 0.36% 59
2024
Q4
$5.61M Sell
21,538
-112
-0.5% -$33.2K 0.3% 69
2024
Q3
$6.98M Sell
21,650
-285
-1% -$93.2K 0.44% 44
2024
Q2
$6.85M Sell
21,935
-67
-0.3% -$19.7K 0.47% 38
2024
Q1
$6.26M Sell
22,002
-189
-0.9% -$55.3K 0.43% 46
2023
Q4
$6.39M Sell
22,191
-2
-0% -$545 0.46% 45
2023
Q3
$5.96M Sell
22,193
-171
-0.8% -$42.7K 0.47% 44
2023
Q2
$4.97M Sell
22,364
-23
-0.1% -$5.34K 0.38% 66
2023
Q1
$5.41M Sell
22,387
-318
-1% -$78.1K 0.44% 53
2022
Q4
$5.96M Buy
22,705
+1,288
+6% +$345K 0.5% 44
2022
Q3
$4.83M Buy
21,417
+57
+0.3% +$13.8K 0.43% 52
2022
Q2
$5.2M Buy
21,360
+79
+0.4% +$19.4K 0.47% 45
2022
Q1
$5.15M Sell
21,281
-137
-0.6% -$31.5K 0.39% 57
2021
Q4
$4.82M Sell
21,418
-1,000
-4% -$211K 0.35% 68
2021
Q3
$4.77M Sell
22,418
-74
-0.3% -$17K 0.37% 60
2021
Q2
$5.48M Sell
22,492
-65
-0.3% -$16K 0.42% 49
2021
Q1
$5.61M Buy
22,557
+10
+0% +$2.39K 0.46% 45
2020
Q4
$5.18M Sell
22,547
-109
-0.5% -$25.1K 0.45% 46
2020
Q3
$5.76M Buy
22,656
+289
+1% +$71.6K 0.56% 38
2020
Q2
$5.28M Buy
22,367
+519
+2% +$118K 0.56% 40
2020
Q1
$4.43M Buy
21,848
+202
+0.9% +$44.1K 0.57% 40
2019
Q4
$5.22M Buy
21,646
+98
+0.5% +$21.6K 0.52% 45
2019
Q3
$4.17M Sell
21,548
-755
-3% -$145K 0.45% 51
2019
Q2
$4.11M Sell
22,303
-135
-0.6% -$24.2K 0.45% 54
2019
Q1
$4.26M Sell
22,438
-404
-2% -$77.2K 0.47% 51
2018
Q4
$4.45M Buy
22,842
+153
+0.7% +$29.8K 0.55% 43
2018
Q3
$4.7M Buy
22,689
+64
+0.3% +$12.6K 0.5% 45
2018
Q2
$4.18M Buy
22,625
+331
+1% +$58.5K 0.47% 51
2018
Q1
$3.8M Sell
22,294
-603
-3% -$111K 0.44% 54
2017
Q4
$3.98M Buy
22,897
+255
+1% +$45.1K 0.44% 54
2017
Q3
$4.22M Buy
22,642
+873
+4% +$155K 0.5% 48
2017
Q2
$3.75M Buy
21,769
+2,546
+13% +$414K 0.46% 49
2017
Q1
$3.15M Buy
19,223
+1,435
+8% +$238K 0.4% 63
2016
Q4
$2.6M Buy
17,788
+69
+0.4% +$10.4K 0.35% 72
2016
Q3
$2.96M Buy
17,719
+680
+4% +$115K 0.4% 61
2016
Q2
$2.59M Sell
17,039
-250
-1% -$38.9K 0.35% 73
2016
Q1
$2.59M Sell
17,289
-1,935
-10% -$287K 0.35% 69
2015
Q4
$3.12M Buy
19,224
+180
+0.9% +$28.3K 0.44% 58
2015
Q3
$2.63M Buy
19,044
+85
+0.4% +$13.4K 0.38% 69
2015
Q2
$2.91M Buy
18,959
+260
+1% +$41.6K 0.39% 65
2015
Q1
$2.99M Buy
18,699
+195
+1% +$30.7K 0.42% 57
2014
Q4
$2.95M Hold
18,504
0.39% 66
2014
Q3
$2.6M Buy
18,504
+10,270
+125% +$1.34M 0.36% 74
2014
Q2
$975K Buy
8,234
+1,465
+22% +$170K 0.13% 160
2014
Q1
$836K Sell
6,769
-71
-1% -$8.61K 0.12% 174
2013
Q4
$781K Hold
6,840
0.12% 174
2013
Q3
$766K Buy
6,840
+250
+4% +$27.1K 0.13% 174
2013
Q2
$650K Buy
+6,590
New +$684K 0.11% 188

Other funds holding AMGN

Parsons Capital Management's AMGN Position: Q2 2026 in Review

Parsons Capital Management increased its Amgen (AMGN) stake by 3.4% in Q2 2026, buying an estimated $267K and bringing the position to 23,390 shares worth $8.47M. The position accounts for 0.38% of the portfolio, ranked #56.

Parsons Capital Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Parsons Capital Management held 23,390 shares of Amgen worth $8.47M as of Q2 2026.
  • Parsons Capital Management bought 780 Amgen shares in Q2 2026, an estimated $267K.
  • Amgen made up 0.38% of Parsons Capital Management's portfolio in Q2 2026, its #56 holding.
  • Parsons Capital Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.